.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Healthtrust
QuintilesIMS
Chubb
Farmers Insurance
US Army
Argus Health
Novartis
Mallinckrodt
Julphar

Generated: July 26, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title:Methods for treating HCV
Abstract: This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.
Inventor(s): Ray; Adrian S. (Burlingame, CA), Link; John O. (San Francisco, CA), Oldach; David W. (Chapel Hill, NC), Delaney, IV; William E. (Foster City, CA), Mo; Hongmei (Palo Alto, CA), Yang; Cheng Yong (Foster City, CA)
Assignee: Gilead Pharmasset LLC (Foster City, CA)
Application Number:13/875,252
Patent Claims: 1. A method of treating an HCV infection in a human, comprising administering to the human: 1) compound 10 having the structure: ##STR00075## or a pharmaceutically acceptable salt thereof and 2) compound 6 having the structure: ##STR00076## or a pharmaceutically acceptable salt thereof, wherein the method does not include administering interferon.

2. The method of claim 1 wherein compound 10 and compound 6 are administered orally.

3. The method of claim 1 wherein ribavirin an interferon is not administered to the human.

4. The method of claim 1 further comprising administering ribavirin to the human.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
QuintilesIMS
US Department of Justice
Federal Trade Commission
Deloitte
Daiichi Sankyo
UBS
Argus Health
McKinsey
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot